T. Rowe Price Associates’s Elicio Therapeutics ELTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,270
Closed -$124K 2995
2021
Q3
$124K Buy
+1,270
New +$124K ﹤0.01% 2797